Breaking News Instant updates and real-time market news.

TMO

Thermo Fisher

$151.19

0.41 (0.27%)

09:49
10/18/16
10/18
09:49
10/18/16
09:49

Thermo Fisher demand trends remain soft, says Cleveland Research

Cleveland Research said recent work continues to indicate demand trends over the past few months remain soft as European government, U.S. academic, and global pharma companies have incrementally slowed their growth in R&D spending. Consequently, the firm continues to expect 3Q16 organic growth of 3% for Thermo Fisher but believes the company needs to raise FY16 guidance by 7c-9c to reflect FEI accretion. Cleveland rates Thermo Fisher a Neutral.

  • 26

    Oct

  • 27

    Oct

TMO Thermo Fisher
$151.19

0.41 (0.27%)

08/18/16
CANT
08/18/16
NO CHANGE
Target $165
CANT
Speculative Buy
Thermo Fisher unlikely to acquire Illumina, says Cantor
Cantor Fitzgerald analyst Bryan Brokmeier believes it is unlikely that Thermo Fisher (TMO) will attempt to acquire Illumina (ILMN). Even if Thermo were to attempt a deal, the merger would be unlikely to close, Brokmeier tells investors in an intraday research note. If Illumina is a willing seller, however, Roche (RHHBY) may reconsider a bid, the analyst contends. He recommends investors stay on the sidelines with respect to Illumina shares. Brokmeier has a Hold rating on the name with a $165 price target. The analyst continues to believe Roche is the most likely acquirer of Pacific Biosciences (PACB).
08/24/16
CLVD
08/24/16
NO CHANGE
CLVD
Thermo Fisher, VWR Q3 estimates trimmed at Cleveland Research
Cleveland Research analyst Steve Willoughby's research suggests the Life Science Industry has gotten off to a slow start in Q3 due to a modest deceleration among pharma customers, European softness following Brexit, and concerns over a slowdown in US government funding. The analyst trimmed estimates on Thermo Fisher (TMO) and VWR (VWR) pending further research.
09/09/16
CLVD
09/09/16
DOWNGRADE
CLVD
Neutral
Thermo Fisher downgraded to Neutral from Buy at Cleveland Research
Cleveland Research analyst Steve Willoughby downgraded Thermo Fisher to Neutral following checks that indicate softer trends. The firm's feedback points to concerns over the remainder of the year and the polity change in China that could impact year-end equipment sales in the country.
09/22/16
JPMS
09/22/16
INITIATION
Target $180
JPMS
Overweight
Thermo Fisher reinstated with Overweight, added to Focus List at JPMorgan
JPMorgan analyst Tycho Peterson reinstated Thermo Fisher Scientific with an Overweight rating and raised his price target for the shares to $180 from $160. The rating is unchanged from the firm's prior coverage. Peterson added Thermo to his firm's Analyst Focus List as a value pick.

TODAY'S FREE FLY STORIES

BA

Boeing

$252.46

-0.62 (-0.24%)

07:09
09/20/17
09/20
07:09
09/20/17
07:09
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

MTCH

Match Group

$23.45

-0.02 (-0.09%)

07:08
09/20/17
09/20
07:08
09/20/17
07:08
Recommendations
Match Group analyst commentary  »

Match Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:08
09/20/17
09/20
07:08
09/20/17
07:08
Hot Stocks
Breaking Hot Stocks news story on General Mills »

General Mills down 4.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

KPTI

Karyopharm

$10.52

-0.34 (-3.13%)

07:07
09/20/17
09/20
07:07
09/20/17
07:07
Hot Stocks
Karyopharm: 'successful' outcome from Phase 2 portion of Phase 2/3 SEAL study »

Karyopharm reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:05
09/20/17
09/20
07:05
09/20/17
07:05
Hot Stocks
General Mills CEO says FY18 priority is 'strengthening our topline performance' »

"Our number one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

SNY

Sanofi

$49.10

0.46 (0.95%)

, ALNY

Alnylam

$75.04

-0.96 (-1.26%)

07:05
09/20/17
09/20
07:05
09/20/17
07:05
Hot Stocks
Sanofi and Alnylam report topline results of patisiran in ATTR amyloidosis »

Sanofi's (SNY)…

SNY

Sanofi

$49.10

0.46 (0.95%)

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ADBE

Adobe

$156.60

0.83 (0.53%)

07:04
09/20/17
09/20
07:04
09/20/17
07:04
Recommendations
Adobe analyst commentary  »

Adobe near-term weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

WDC

Western Digital

$89.92

0.74 (0.83%)

07:04
09/20/17
09/20
07:04
09/20/17
07:04
Technical Analysis
Technical View: Western Digital falls as Toshiba selects Bain-led group as buyer »

Toshiba (TOSBF, TOSYY)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:04
09/20/17
09/20
07:04
09/20/17
07:04
Hot Stocks
General Mills CEO says 'confident in improved momentum' for rest of year »

CEO Harmening said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

SIX

Six Flags

$56.75

-0.32 (-0.56%)

07:03
09/20/17
09/20
07:03
09/20/17
07:03
Hot Stocks
Six Flags says no expected material impact from Mexico earthquake »

Six Flags Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

PG

Procter & Gamble

$94.17

1.02 (1.10%)

07:03
09/20/17
09/20
07:03
09/20/17
07:03
Hot Stocks
Procter & Gamble: Peltz 'lacks specific qualities' P&G seeking in board members »

The Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:03
09/20/17
09/20
07:03
09/20/17
07:03
Hot Stocks
General Mills reports Q1 gross margin down 150 bps to 34.8% »

Gross margin decreased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

07:02
09/20/17
09/20
07:02
09/20/17
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 9/15 MBA Mortgage…

IDN

Intellicheck

07:02
09/20/17
09/20
07:02
09/20/17
07:02
Initiation
Intellicheck initiated  »

Intellicheck initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

, SNY

Sanofi

$49.10

0.46 (0.95%)

07:02
09/20/17
09/20
07:02
09/20/17
07:02
Hot Stocks
Alnylam, Sanofi say APOLLO Phase 3 study met primary, secondary endpoints »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

SNY

Sanofi

$49.10

0.46 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:02
09/20/17
09/20
07:02
09/20/17
07:02
Earnings
General Mills backs FY18 adjusted EPS growth of 1%-2%, consensus $3.10 »

Reaffirms fiscal 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

07:00
09/20/17
09/20
07:00
09/20/17
07:00
Earnings
General Mills reports Q1 adjusted EPS 71c, consensus 76c »

Reports Q1 revenue $3.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CELG

Celgene

$143.47

0.63 (0.44%)

, XLRN

Acceleron

$38.97

-0.41 (-1.04%)

06:59
09/20/17
09/20
06:59
09/20/17
06:59
Recommendations
Celgene, Acceleron analyst commentary  »

Jefferies sees Celgene…

CELG

Celgene

$143.47

0.63 (0.44%)

XLRN

Acceleron

$38.97

-0.41 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Sep

ACH

Aluminum Corp. of China

$21.31

0.28 (1.33%)

06:59
09/20/17
09/20
06:59
09/20/17
06:59
Technical Analysis
Technical View: Aluminum Corp. of China at new 52-week high in pre-market »

The stock was last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$94.87

0.49 (0.52%)

06:58
09/20/17
09/20
06:58
09/20/17
06:58
Periodicals
Equifax may be able to spend $1 per customer over data breach, Bloomberg says »

Equifax may be able to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

NBY

NovaBay

$4.45

0.1 (2.30%)

06:54
09/20/17
09/20
06:54
09/20/17
06:54
Hot Stocks
NovaBay receives noncompliance notification from NYSE »

NovaBay Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$156.60

0.83 (0.53%)

06:54
09/20/17
09/20
06:54
09/20/17
06:54
Recommendations
Adobe analyst commentary  »

Jefferies ups Adobe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PZRX

PhaseRx

$0.78

0.055 (7.64%)

06:53
09/20/17
09/20
06:53
09/20/17
06:53
Hot Stocks
PhaseRx argininosuccinate lyase deficiency treatment granted FDA orphan status »

PhaseRx's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$55.65

-0.26 (-0.47%)

06:52
09/20/17
09/20
06:52
09/20/17
06:52
Technical Analysis
Technical View: iShares MSCI Mexico falls, levels to watch »

The iShares MSCI Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXLT

Baxalta

06:52
09/20/17
09/20
06:52
09/20/17
06:52
Hot Stocks
Baxalta treatment of hemophilia A granted FDA orphan designation »

Baxalta's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.